Store
In Vitro Diagnostics (IVD) in India
Publication Date: June 30, 2022
Tags: APAC, Asia, Coagulation, Genetic Diseases, Hematology, Histology and Cytology, Immunoassay, In Vitro Diagnostics (IVD), Infectious Diseases, Molecular Diagnostics, Oncology and Cancer, Point-of-Care (POC) Testing
Pages: 55
SKU: 22-709
Kalorama Information is proud to announce a comprehensive new market research report, offering an in-depth overview of the In Vitro Diagnostics (IVD) market in India. This report delves into the IVD discipline, covering reagents, consumables, calibrators, and controls across various sub-segments, providing a detailed analysis of market trends and influences.
Report Highlights:
- Clinical Chemistry: Includes routine lab testing such as substrates, enzymes, homogeneous immunoassays, proteins, ISE (non-POC), HBA1c (non-POC), as well as urinalysis and blood chemistry testing.
- Immunoassays: Covers a range of tests including hormones and thyroid function, tumor markers, allergy, anemia, neonatal and prenatal tests, interleukins, PCT, toxicology, and common infectious diseases like HIV, hepatitis, and influenza.
- Microbiology and Molecular Testing: Features manual and automated tests, culture media, latex tests, transport media, blood culture, sensitivity discs, Gram and other stains, MTB culture, Mycoplasma, Ureaplasma, and nucleic acid testing.
- Point-of-Care Testing: Includes all POC tests for cardiology, toxicology, coagulation, diabetes, and infectious diseases, along with POC and non-POC blood gas and electrolytes, and glucose self-monitoring tests.
- Histology/Cytology: Encompasses PAP, HE, IHC, ISH, FISH, and primary and secondary antibodies.
The report also includes an analysis of trends influencing the industry, backed by country-level data on disease incidence, life expectancy, population demographics, economic status, healthcare utilization, and other market drivers.
Market Data:
- Focused on the Indian IVD market at the manufacturers’ level.
- Market data for the year 2021, with forecast data extending to 2026.
- Compound annual growth rates (CAGRs) provided for the 2021-2026 period.
Table: India In Vitro Diagnostic Sales, by Extracted Market Segment, 2021-2026 (in millions $)
| Segment | Sales $ 2021 |
Sales $ 2026 |
CAGR |
| General Chemistry | $XX Million | $XX Million | XX% |
| Blood Gas Analysis | $XX Million | $XX Million | XX% |
| Urinalysis | $XX Million | $XX Million | XX% |
| Infectious Disease Immunoassays | $XX Million | $XX Million | XX% |
| Other Immunoassays | $XX Million | $XX Million | XX% |
| Blood Bank Screening Immunoassays | $XX Million | $XX Million | XX% |
| POC Glucose | $XX Million | $XX Million | XX% |
| POC Other | $XX Million | $XX Million | XX% |
| ID/AST | $XX Million | $XX Million | XX% |
| Microbiology Molecular | $XX Million | $XX Million | XX% |
| HPV | $XX Million | $XX Million | XX% |
| CTC | $XX Million | $XX Million | XX% |
| Other Histology | $XX Million | $XX Million | XX% |
| Others | $XX Million | $XX Million | XX% |
| Total | $XX Million | $XX Million | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter 1: Executive Summary
Industry Overview
Scope and Methodology
Indian IVD Market Summary
- Figure 1-1: India In Vitro Diagnostic Sales by Market Segment, 2021-2026 ($ millions)
Chapter 2: India Overview
Population
- Table 2-1: Total Midyear Population by Broad Age Group: India (million persons), 2010-2060
- Figure 2-1: Total Midyear Population by Broad Age Group: India (million persons), 2010-2060
- Figure 2-2: Total Number of Births in India by Year, 1990-2020
- Figure 2-3: India Life Expectancy at Birth in Years, 2000-2100
Health Indicators
General Health
Disease Profiles in India
- Table 2-2: Top 5 Cancers Affecting Indian Population (ranked by total number of cases), 2020
Economy and Health Spending
- Figure 2-4: India GDP, GDP (PPP) and Health Spending, 1990-2020 (billions of $)
- Figure 2-5: India Real GDP Growth, Inflation Rate (consumer prices) 2017-2020
Health Infrastructure
Medical Facilities
Hospital Bed Density
- Figure 2-6: Hospital Bed Density per 1,000 Population by Country, 2020 Estimates
Physicians and Health Professionals
- Figure 2-7: Physician Density per 1,000 Population by Country, 2020 Estimates
Medical Device Regulation
Chapter 3: IVD Markets in India
Market Summary
- Table 3-1: India In Vitro Diagnostic Sales by Extracted Market Segment, 2021-2026 ($ millions)
- Figure 3-1: India In Vitro Diagnostic Sales by Broad Market Segment, 2021 – 2026 ($ millions)
- Figure 3-2: India In Vitro Diagnostic Sales by Broad Market Segment, 2021 Market Distribution (%)
Clinical Chemistry, Hematology, Coagulation
- Figure 3-3: India – Clinical Chemistry (General Chemistries, Blood Gas Analysis, Urinalysis), Hematology, Coagulation Market, 2021 – 2026 ($ millions)
Immunoassay
- Figure 3-4: India – Immunoassay Market Value by Segment (Infectious Disease, Other Diseases, Blood Bank Screening), 2021 – 2026 ($ millions)
Microbiology/Molecular
- Figure 3-5: India – Microbiology/Molecular Testing Market Value by Segment (ID/AST, Molecular), 2021 – 2026 ($ millions)
Point-of-Care
- Figure 3-6: India – POC Market Value by Segment (Glucose, Infectious Disease, Others), 2021 – 2026 ($ millions)
Histology
- Figure 3-7: India – Histology Market (HPV, CTC, Others), 2021 – 2026 ($ millions)
Chapter 4: Company Profiles
Abbott India Limited
- Table 4-1: Abbott India Summary
Company Overview
Product News
Performance Review
- Table 4-2: Abbott Revenues 2019-2021 (in millions $)
Becton Dickinson (BD) India
- Table 4-3: BD India Summary
Company Overview
Product News
Performance Review
- Table 4-4: BD Corporation Revenue (2019-2021 ($ millions)
bioMérieux India Private Limited
- Table 4-5: bioMérieux India Corporate Summary
Company Overview
Product News
Performance Review
- Table 4-6 : bioMérieux Revenues (2019-2021) ($ millions)
Bio-Rad Laboratories India Private Limited
- Table 4-7: Bio-Rad Labs India Summary
Company Overview
Product News
Performance Review
- Table 4-8: Bio-Rad Corporation Revenue (2019-2021) ($ millions)
Danaher Corporation India
- Table 4-9: Danaher India Summary
Company Overview
Product News
Performance Review
- Table 4-10 Danaher Revenue (2019-2021) ($ millions)
Fujifilm India Private Limited
- Table 4-11: Fujifilm India Summary
Company Overview
Product News
Performance Review
- Table 4-12: Fujifilm (2019-2021) ($ billions)
QIAGEN India Pvt. Ltd
- Table 4-13: QIAGEN India Summary
Company Overview
Product News
Performance Review
- Table 4-14: QAIGEN 2019-2021) ($ millions)
Roche India
- Table 4-15: Roche India Corporate Summary
Company Overview
Product News
Performance Review
- Table 4-16: Roche Diagnostics (2019-2021) ($ millions)
Siemens Healthcare Private Limited
- Table 4-17: Siemens Healthineers Corporate Summary
Company Overview
Product News
Performance Review
- Table 4-18: Siemens Healthineers (2019-2021) ($ millions)
Sysmex India Pvt Ltd.
- Table 4-19: Sysmex India Summary
Company Overview
Product News
Performance Review
- Table 4-20: Sysmex (2019-2021) ($ millions)
Thermo Fisher Scientific India Pvt. Ltd.
- Table 4-21: Thermo Fisher India Summary
Company Overview
Product News
Performance Review
- Table 4-22: Thermo Fisher (2019-2021) ($ millions)
Transasia Bio-Medical
- Table 4-23: TransAsia Bio-Medical Summary
Company Overview
Product News
Related products
IVD Market Trends Report, March 2023
March 17, 2023
Diagnostic testing remains a cornerstone in healthcare, aiding physicians in diagnosis and providing crucial information for treatments like precision medicine. As we navigate the aftermath of the COVID-19 pandemic, the IVD market is evolving, driven by new products, shifts in global health spending, regulatory updates, and changing disease trends. Despite these shifts, the IVD market…
Price range: $3,000.00 through $4,500.00
Cell and Gene Therapy Deals Analysis, 2021-2024
June 3, 2024
Kalorama Information’s Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 offers a comprehensive look at the dynamic and rapidly evolving cell and gene therapy market. This report highlights the significant deal-making activities that have taken place from Q1 2021 to Q1 2024, providing valuable insights for companies and…
Price range: $6,300.00 through $9,450.00
The World Market for Vaccines, 2024
February 22, 2024
Vaccines are a cornerstone of preventive medicine, offering long-term or permanent immunity against diseases. They have been instrumental in near-eliminating many deadly diseases, making vaccination one of the greatest public health achievements of the 20th century. Kalorama Information’s latest report, The World Market for Vaccines, 2024, provides a comprehensive analysis of adult…
Price range: $5,000.00 through $7,875.00
